Related Experiment Video
Updated: Aug 26, 2026
06:34
An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
Published on: December 1, 2017
[Examination about the clinical efficiency of influenza vaccination (author's transl)]
Laryngologie, Rhinologie, Otologie
|January 1, 1976
Abstract:
A single blind study was performed to test the efficiency of influenza-vaccination against various clinical parameters. The parameters "sickness", "rhinitis" and "medication" were reduced significantly during the months of november to march, namely by 64.8%, 19.9% and 39.6%. Apart from the overall reduction of rhinitis especially the severe forms were strongly reduced. However this effect disappeared after five months. The parameters "fever", "cough" and "asthma" showed no difference.
Related Concept Videos
01:51Vaccinations
Overview
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...